NYSE ARCA | ETF
Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries.
While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 3.70% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 3.19% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 2.96% |
| MDT | Medtronic PLC | Healthcare | Medical Devices | 2.90% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 2.70% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 2.57% |
| MTD | Mettler-Toledo International Inc | Healthcare | Diagnostics & Research | 2.53% |
| XTSLA | BlackRock Cash Funds Treasury SL Agency | 2.50% | ||
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 2.43% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.37% |
| NOVN | Novartis AG | Healthcare | Drug Manufacturers - General | 2.19% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 2.16% |
| COO | The Cooper Companies Inc. | Healthcare | Medical Instruments & Supplies | 2.10% |
| NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 2.04% |
| LH | Laboratory Corporation of America Holdings | Healthcare | Diagnostics & Research | 1.99% |
| IQV | IQVIA Holdings Inc | Healthcare | Diagnostics & Research | 1.97% |
| GEN | Genmab A/S | Other | Other | 1.94% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 1.89% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 1.86% |
| A | Agilent Technologies Inc | Healthcare | Diagnostics & Research | 1.81% |